Wyoming MPJE (Pharmacy Jurisprudence) Practice Exam

Disable ads (and more) with a membership for a one time $4.99 payment

Prepare for the Wyoming MPJE (Pharmacy Jurisprudence) Exam with comprehensive flashcards and multiple choice questions complete with hints and explanations. Ace your exam!

Practice this question and more.


What does Phase 2 of clinical trials primarily test for?

  1. Efficacy, slightly larger group of people with the disease

  2. Drug approval, general population

  3. Long-term safety, very large population

  4. Short-term safety, small healthy population

The correct answer is: Efficacy, slightly larger group of people with the disease

Phase 2 of clinical trials primarily test for efficacy in a slightly larger group of people with the disease. This phase aims to gather more information on the drug's effectiveness and potential side effects in individuals who have the condition of interest. Option B is incorrect because drug approval typically occurs after Phase 3 trials, not Phase 2. Option C is incorrect as long-term safety is usually assessed in Phase 4 trials after the drug has already been approved and is on the market. Option D is incorrect because short-term safety is usually evaluated in Phase 1 trials, not Phase 2.